9 Meters Biopharma, Inc. Financial Ratios — NMTRQ Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	-99.75	-198.92
Return on Assets (%)	- -	-265.09	-157.09	-111.13	-319.61	-666.3	-460.37	-276.67	-82.34	-105.05
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	17.6	2.06	5.15	18.11	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-97.71	-58.86	-77.5	-142.98	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-97.71	-58.86	-78.15	-146.2	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	128.57	- -	- -	- -	- -	- -
Pretax Margin (%)	-99.62	-97.36	-105.72	-152.79	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-99.74	-97.48	-105.75	-152.84	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-99.74	-97.48	-105.75	-152.84	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	-99.75	-198.92

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Debt	1	5	4	- -	9	5	3	- -	- -	20
ST Debt	1	5	4	- -	9	5	3	- -	- -	20
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.23	-0.76	-0.58	-0.01	-0.77	-0.29	-0.13	-0.01	-0.01	-0.47
Net Debt/EBITDA	-0.23	-0.75	-0.56	0.24	-0.74	0.03	0.06	1.77	1.48	-0.17
Total Debt/EBIT	-0.23	-0.76	-0.58	-0.01	-0.77	-0.29	-0.13	-0.01	-0.01	-0.47
Net Debt/EBIT	-0.23	-0.75	-0.56	0.24	-0.74	0.03	0.06	1.76	1.48	-0.17
EBITDA to Interest Expense	-50.98	-4.02	-4.64	-7.04	-25.59	-2.96	-13.29	-5.3	-670.73	-15.75
EBITDA-CapEx/Interest Expense	-50.98	-4.02	-4.64	-7.04	-25.68	-2.96	-13.3	-6.09	-723.83	-15.75
EBIT to Interest Expense	-50.98	-4.02	-4.68	-7.2	-25.6	-2.96	-13.3	-5.3	-670.89	-15.75
Interest Expense	- -	2	1	1	- -	6	2	4	- -	3
Common Equity/Total Assets	-27.76	-77.8	-120.69	38.49	-1,524.71	-56.69	-181.51	82.08	82.92	7.24
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.52	0.27	2.14
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	0.52	0.27	0.23
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.43	0.23	0.16
Total Debt/Equity (%)	-147.2	-101.96	-65.33	1.53	-70.42	-142.02	-33.57	0.72	0.4	821.87
Total Debt/Capital (%)	311.86	5,189.8	-188.45	1.5	-238.11	337.97	-50.54	0.71	0.4	89.15
Total Debt/Total Assets (%)	40.86	79.33	78.85	0.59	1,073.76	80.52	60.93	0.59	0.33	59.52
Net Debt to Equity	-147.01	-100.02	-63.24	-56.87	-67.5	14.55	14.65	-117.72	-112.96	290.35
Net Debt/Capital (%)	312.7	498,900	-172.05	-131.87	-207.73	12.7	12.83	690.65	899.9	73.49
EBITDA	-3	-7	-6	-6	-11	-18	-24	-21	-32	-42
EBITDA-CapEx	-3	-7	-6	-6	-11	-18	-24	-25	-34	-42
Operating Income (Loss)	-3	-7	-6	-6	-11	-18	-24	-21	-32	-42

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Cash Ratio	- -	0.01	0.01	0.37	0.03	0.57	0.31	5.53	5.56	0.41
Current Ratio	0.77	0.55	0.15	1.01	0.06	0.63	0.35	5.68	5.91	1.08
Quick Ratio	0.35	0.32	0.07	0.58	0.03	0.57	0.31	5.53	5.56	0.41
CFO/Avg Current Liab	- -	-1.07	-0.16	-1.17	-0.6	-1.31	-1.44	-1.78	-3.85	-1.9
Common Equity/Total Assets	-27.76	-77.8	-120.69	38.49	-1,524.71	-56.69	-181.51	82.08	82.92	7.24
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.52	0.27	2.14
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	0.52	0.27	0.23
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.43	0.23	0.16
Total Debt/Equity (%)	-147.2	-101.96	-65.33	1.53	-70.42	-142.02	-33.57	0.72	0.4	821.87
Total Debt/Capital (%)	311.86	5,189.8	-188.45	1.5	-238.11	337.97	-50.54	0.71	0.4	89.15
Total Debt/Total Assets (%)	40.86	79.33	78.85	0.59	1,073.76	80.52	60.93	0.59	0.33	59.52
CFO/Total Liabilities	-156.95	-65.37	-16.62	-211.95	-39.29	-149.99	-120.5	-276.63	-343.96	-121.13
CFO/CapEx	- -	- -	- -	- -	-131.6	-1,087.95	-1,505.61	-6.09	-11.76	-13,104.58
Altman's Z-Score	-8.72	-6.36	-27.62	-13.9	-98.26	-17.66	-35.53	1.97	3.05	-12.92

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Accounts Receivable Turnover	- -	5.11	3.92	5.42	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	71.42	93.02	67.34	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	6.67	4.87	3.83	3.23	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	54.72	74.96	95.28	113.04	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	10.57	4.47	5.9	0.64	-0.03	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	34.52	81.67	61.89	566.4	-11,342.59	- -	- -	- -	- -
Cash Conversion Cycle	- -	91.62	86.3	100.73	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	16.7	18.06	-27.94	- -	- -	- -	- -	- -	- -
Inventories	1	3	1	1	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	1	3	1	1	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Market Capitalization	- -	- -	- -	7	4	30	11	88	126	8
- Cash & Cash Equivalents	- -	- -	- -	1	- -	6	5	38	47	13
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	5	4	- -	9	5	3	- -	- -	20
Enterprise Value	1	5	4	5	13	30	10	50	80	15
Total Capital	- -	- -	-2	3	-4	2	-6	32	42	22
Total Debt/Capital (%)	311.86	5,189.8	-188.45	1.5	-238.11	337.97	-50.54	0.71	0.4	89.15
Total Debt / EV	1	1.02	1.03	0.01	0.68	0.18	0.34	- -	- -	1.29
EV/Sales	0.23	0.44	0.44	1.33	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	5	36	29	9	45	119	8
Diluted Enterprise Value	1	5	4	3	44	28	8	8	72	15
EV per Share	21.47	135.96	98.13	138.65	175.43	22.69	4.88	4.91	6.16	1.17
TTM Sales	3	11	8	4	- -	- -	- -	- -	- -	- -
TTM EBITDA	-3	-7	-6	-6	-11	-18	-24	-21	-32	-42
TTM Operating Income	-3	-7	-6	-6	-11	-18	-24	-21	-32	-42
TTM Cash Flow to Firm	-4	-6	- -	-8	-5	-9	-16	-15	-29	-35
TTM Free Cash Flow to Firm	-4	-6	- -	-8	-5	-9	-16	-12	-27	-35

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Price/Free Cash Flow	- -	- -	- -	-0.57	-7.17	-1.89	-0.52	-2.8	-4.41	-0.22
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	1	5	4	5	13	30	10	50	80	15
Low Price	- -	- -	- -	95	40.32	21.2	4.03	3.7	8.11	0.5
EV/Sales	0.23	0.44	0.44	1.33	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-0.93	-4.62	-5.2	-0.84	-0.57	-4.17	-1.12
Price/Earnings High	- -	- -	- -	-1.84	-15.11	-25.88	-2.66	-1.05	-7.47	-3.05
Price/Earnings Low	- -	- -	- -	-0.42	-2.07	-1.09	-0.25	-0.32	-2.68	-0.15
Price/Book Value	- -	- -	- -	2.74	-0.36	-8.24	-1.14	2.73	3.04	3.42
Price/Book Value Average	- -	- -	- -	3.27	-0.53	-36.16	-2.81	2.1	3.92	20.48
Price/Book Value High	- -	- -	- -	6.49	-1.74	-180.03	-8.87	3.88	7.01	55.94
Price/Book Value Low	- -	- -	- -	1.49	-0.24	-7.56	-0.83	1.18	2.52	2.72
Price/Tangible Book Value	- -	- -	- -	95.94	-0.36	-8.24	-1.14	2.73	3.04	3.42
Price/Tangible Book Value Average	- -	- -	- -	114.7	-0.53	-36.16	-2.81	2.1	3.92	20.48
Price/Tangible Book Value High	- -	- -	- -	227.52	-1.74	-180.03	-8.87	3.88	7.01	55.94
Price/Tangible Book Value Low	- -	- -	- -	52.08	-0.24	-7.56	-0.83	1.18	2.52	2.72
Price/Sales	- -	- -	- -	1.19	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	1.42	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	2.82	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	0.65	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-0.57	-7.11	-1.89	-0.52	-2.34	-4.04	-0.22
Price/Cash Flow Average	- -	- -	- -	-0.69	-10.53	-8.28	-1.27	-1.79	-5.2	-1.31
Price/Cash Flow High	- -	- -	- -	-1.36	-34.41	-41.22	-4.01	-3.32	-9.32	-3.58
Price/Cash Flow Low	- -	- -	- -	-0.31	-4.7	-1.73	-0.37	-1.01	-3.34	-0.17
Price/Free Cash Flow Average	- -	- -	- -	-0.69	-10.61	-8.29	-1.27	-2.14	-5.69	-1.31
Price/Free Cash Flow High	- -	- -	- -	-1.36	-34.67	-41.26	-4.01	-3.97	-10.18	-3.58
Price/Free Cash Flow Low	- -	- -	- -	-0.31	-4.74	-1.73	-0.37	-1.2	-3.65	-0.17
EV/Sales Average	0.23	0.44	0.44	1.66	- -	- -	- -	- -	- -	- -
EV/Sales High	0.23	0.44	0.44	3.63	- -	- -	- -	- -	- -	- -
EV/Sales Low	0.23	0.44	0.44	0.56	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-0.23	-0.75	-0.56	-1.16	-1.32	-7.24	-1.06	-1.39	-3.67	-1.34
EV/EBITDA High	-0.23	-0.75	-0.56	-2.54	-2.63	-36.16	-3.46	-4.07	-7.74	-3.36
EV/EBITDA Low	-0.23	-0.75	-0.56	-0.39	-1	-1.49	-0.27	-0.01	-1.83	-0.32
EV/EBIT Average	-0.23	-0.75	-0.56	-1.13	-1.32	-7.23	-1.05	-1.39	-3.67	-1.34
EV/EBIT High	-0.23	-0.75	-0.56	-2.48	-2.63	-36.12	-3.46	-4.06	-7.74	-3.36
EV/EBIT Low	-0.23	-0.75	-0.56	-0.38	-1	-1.49	-0.27	-0.01	-1.83	-0.32
Last Price	- -	- -	- -	175	61	23.1	5.57	8.59	9.79	0.63
High Price	- -	- -	- -	415	295	505	43.2	12.2	22.6	10.3
Enterprise Value Average	1	5	4	7	15	132	26	30	116	56
Enterprise Value High	1	5	4	15	29	658	84	87	245	141
Enterprise Value Low	1	5	4	2	11	27	7	- -	58	14

Shares Outstanding	- -	- -	- -	- -	- -	1	2	10	13	13
Diluted Weighted Avg Shares	- -	- -	- -	- -	1	1	2	5	12	13
Basic Weighted Avg Shares	- -	- -	- -	- -	1	1	2	5	12	13
Revenue per Share	130.28	426.91	312.69	147.28	- -	- -	- -	- -	- -	- -
EBITDA per Share	-127.29	-251.26	-242.33	-210.58	-18.78	-14.7	-14.56	-4.06	-2.6	-3.24
Operating Income per Share	-127.29	-251.26	-244.37	-215.33	-18.79	-14.72	-14.57	-4.06	-2.6	-3.24
Basic EPS, GAAP	-129.94	-416.15	-330.66	-225.11	-19.52	-19.52	-16.23	-11.64	-3.03	-3.38
Basic EPS from Cont Ops	-129.94	-416.15	-330.66	-225.11	-19.52	-19.52	-16.23	-11.64	-3.03	-3.38
Diluted EPS, GAAP	-129.28	-416.15	-328.98	-225.11	-19.52	-19.52	-16.23	-11.64	-3.03	-3.38
Diluted EPS from Cont Ops	-129.28	-416.15	-328.98	-225.11	-19.52	-19.52	-16.23	-11.64	-3.03	-3.38
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-146.47	-280.47	-65.44	-305.33	-8.57	-12.25	-10.78	-3.67	-2.43	-2.87
Free Cash Flow per Basic Share	-146.47	-280.47	-65.44	-305.33	-8.64	-12.26	-10.79	-4.28	-2.63	-2.87
Cash & Equivalents per Share	0.03	2.64	3.24	37.33	4.95	4.39	2.33	3.7	3.64	0.97
Book Value per Share	-14.61	-135.93	-155.17	63.92	-169.52	-2.81	-4.87	3.14	3.22	0.18
Tangible Book Value per Share	-14.61	-135.93	-224.61	1.82	-169.52	-2.81	-4.87	3.14	3.22	0.18

9 Meters Biopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)